Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Munehiro Yoshitomi

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Personalized peptide vaccination]Kyogo Itoh, Ryuji Takahashi, Munehiro Yoshitomi, et al.
Obstetrics and Gynecology|June 11, 2026
Ovarian Vein Thrombosis Associated With Oral Contraceptives and Anomalous Renal Venous DrainageRyu J Mori-Iwatate, Haruka Santa, Shuichiro Sagara, et al.
Asian Journal of Surgery|December 20, 2017
Oncological outcomes after hepatic resection and/or surgical microwave ablation for liver metastasis from gastric cancerTomoki Ryu, Yuko Takami, Yoshiyuki Wada, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 9, 2018
Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI GradeHajime Matsushima, Yuko Takami, Tomoki Ryu, et al.
Internal Medicine (Tokyo, Japan)|December 28, 2017
The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective StudyYoshiyuki Wada, Yuko Takami, Hajime Matsushima, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 11, 2013
Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide VaccineShigeru Yutani, Nobukazu Komatsu, Satoko Matsueda, et al.
Human Vaccines & Immunotherapeutics|February 5, 2013
Current status of immunotherapy for the treatment of biliary tract cancerRyuji Takahashi, Munehiro Yoshitomi, Shigeru Yutani, et al.
Hepatology International|March 1, 2018
Effect of achieving sustained virological response before hepatitis C virus-related hepatocellular carcinoma occurrence on survival and recurrence after curative surgical microwave ablationTomoki Ryu, Yuko Takami, Yoshiyuki Wada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 25, 2008
[A case of intraluminal/external irradiation, chemotherapy and T-tube stent treatment for the local recurrence of the postoperative four-year bile duct cancer]Munehiro Yoshitomi, Hiroyuki Horiuchi, Ryuichi Kawahara, et al.
The Kurume Medical Journal|August 4, 2024
Extrahepatic Portal Venous Gas Is the Strongest Predictor of Mortality in Patients with Portal Venous Gas and Pneumatosis IntestinalisNaohiro Yoshida, Yoshihiko Sadakari, Hiroyuki Nakane, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Personalized peptide vaccination]Kyogo Itoh, Ryuji Takahashi, Munehiro Yoshitomi, et al.
Obstetrics and Gynecology|June 11, 2026
Ovarian Vein Thrombosis Associated With Oral Contraceptives and Anomalous Renal Venous DrainageRyu J Mori-Iwatate, Haruka Santa, Shuichiro Sagara, et al.
Asian Journal of Surgery|December 20, 2017
Oncological outcomes after hepatic resection and/or surgical microwave ablation for liver metastasis from gastric cancerTomoki Ryu, Yuko Takami, Yoshiyuki Wada, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 9, 2018
Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI GradeHajime Matsushima, Yuko Takami, Tomoki Ryu, et al.
Internal Medicine (Tokyo, Japan)|December 28, 2017
The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective StudyYoshiyuki Wada, Yuko Takami, Hajime Matsushima, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 11, 2013
Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide VaccineShigeru Yutani, Nobukazu Komatsu, Satoko Matsueda, et al.
Human Vaccines & Immunotherapeutics|February 5, 2013
Current status of immunotherapy for the treatment of biliary tract cancerRyuji Takahashi, Munehiro Yoshitomi, Shigeru Yutani, et al.
Hepatology International|March 1, 2018
Effect of achieving sustained virological response before hepatitis C virus-related hepatocellular carcinoma occurrence on survival and recurrence after curative surgical microwave ablationTomoki Ryu, Yuko Takami, Yoshiyuki Wada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 25, 2008
[A case of intraluminal/external irradiation, chemotherapy and T-tube stent treatment for the local recurrence of the postoperative four-year bile duct cancer]Munehiro Yoshitomi, Hiroyuki Horiuchi, Ryuichi Kawahara, et al.
The Kurume Medical Journal|August 4, 2024
Extrahepatic Portal Venous Gas Is the Strongest Predictor of Mortality in Patients with Portal Venous Gas and Pneumatosis IntestinalisNaohiro Yoshida, Yoshihiko Sadakari, Hiroyuki Nakane, et al.
Pageof 3